Regulus Therapeutics Inc. (RGLS)
Last closing price (Apr 17 4:00 EDT):
6.96 (-0.29%) ?
Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of microRNA therapeutics to treat a range of diseases primarily in the United States. The company is developing various oligonucleotides, including miR-21 for hepatocellular carcinoma and for kidney fibrosis, miR-122 for hepatitis C virus infection, miR-33 for atherosclerosis, and miR-10b for glioblastoma multiforme treatment. It has strategic alliance with GlaxoSmithKline plc; and collaboration and license agreement with Sanofi, AstraZeneca, Alnylam and Isis, and Biogen Idec MA Inc. The company was founded in 2007 and is headquartered in San Diego, California.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
|William Tanner||Lazard Capital Markets||Buy||Mar 05, '14||11.53||Mar 05, '15||-39.64%|
|Alan Carr||Needham & Company||Buy||Feb 28, '14||11.23||Feb 28, '15||-38.02%|
|Alan Carr||Needham & Company||Buy||Aug 14, '13||8.91||12.00||Aug 14, '14||-21.89%|
|William Tanner||Lazard Capital Markets||Buy||Aug 14, '13||8.91||15.00||Aug 14, '14||-21.89%|
|Jim Birchenough||BMO Capital Markets||Buy||Aug 14, '13||8.91||Aug 14, '14||-21.89%|
|Enoch Kuo||Unaffiliated||Buy||Jul 17, '13||9.66||20.00||Jul 17, '14||-27.95%|
|Alan Carr||Needham & Company||Buy||May 15, '13||7.29||May 15, '14||-4.53%|
|William Tanner||Lazard Capital Markets||Buy||Oct 31, '12||4.78||14.00||Oct 31, '13||46.23%|